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RESULTS: All eight patients favorably appraised the
format of the revised instrument. Patients reported that
the SFB-SUI generally provided an accurate assessment of
their condition and associated bothersomeness. Changes
resulting from the interviews included the addition of one
new item, the deletion of two items, and modiﬁcation of
both response scales. The ﬁnal version of the SFB-SUI
now consists of 8 items.
CONCLUSION: Preliminary investigation of the SFB-SUI
indicates that it is a two-subscale measure for symptom
frequency and bothersomeness speciﬁc to stress urinary
incontinence. Psychometric evaluation will be performed
in subsequent clinical trials being conducted in stress
urinary incontinence patients.
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OBJECTIVES: Overactive bladder (OAB) is characterized
by bothersome symptoms of urinary frequency and
urgency that occur with or without urge incontinence,
and it has been shown to have signiﬁcant impact on
health-related quality of life (HRQL). Since OAB is
deﬁned by symptoms, the evaluation of treatment 
effectiveness should be based upon patient perception.
The purpose of this study was to assess the validity and
responsiveness of a global patient-report measure—the
Perception of Bladder Condition (PBC) in Overactive
Bladder.
METHODS: OAB patients were treated with Tolterodine
Extended Release 4mg/day for 12 weeks. Patient evalua-
tions, which included the PBC, OAB-q (measure of
symptom bother and HRQL), and micturition variables
(3-day diaries: frequency, incontinence, urgency), were
conducted at baseline, 4 weeks, and 12 weeks. The PBC
is a single item that assesses current urinary problems on
a 6-point scale. PBC scores were evaluated with other
measures of treatment efﬁcacy using t-tests and ANOVAs
for all assessment periods.
RESULTS: 865 patients completed the study (mean age =
61 years; 73% female; 89% Caucasian). Higher severity
PBC responses were signiﬁcantly associated with greater
symptom bother and lower HRQL at each assessment
period (p < 0.05). Associations between PBC and mic-
turition variables followed similar patterns. Compared
with patients who did not report improvement on the
PBC, patients who improved demonstrated signiﬁcantly
greater improvement from baseline to week 12 on all
OAB-q scales (p < 0.0001), micturition frequency (p <
0.0001), incontinence episodes (p < 0.002), and urgency
episodes (p < 0.005). Patients reporting major improve-
ment on the PBC (>2 response options) consistently
demonstrated signiﬁcantly greater improvement on other
efﬁcacy measures compared to patients reporting minor
improvement.
CONCLUSIONS: The Perception of Bladder Condition
demonstrated good construct validity and responsiveness
among patients receiving Tolterodine Extended Release 
4mg/day for Overactive Bladder. It appears to be a useful
tool for evaluating patients’ global impressions of bladder
condition in clinical trials of OAB treatments.
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OBJECTIVES: Urinary urgency is a central symptom of
overactive bladder (OAB) and is particularly bothersome
due to its unpredictable nature and consequent impact 
on daily living. There are no objective clinical measures
of urgency and there is a need for a validated, standard-
ized instrument. The purpose of this study was to 
ascertain the validity and responsiveness of the Urgency
Perception Scale (UPS) as an indicator of perceived
urinary urgency.
METHODS: Content validity was assessed by interviews
with OAB patients and clinical experts. Secondary 
analyses of clinical and patient outcome data gathered
from three separate clinical studies of tolterodine
extended release were performed to evaluate the psycho-
metric properties of the UPS. Construct validity was
assessed by correlations between the UPS and micturition
diaries and other patient-reported outcomes including
perception of bladder condition, perception of treatment
beneﬁt, SF-36, King’s Health Questionnaire, Overactive
Bladder Questionnaire, and Overall Treatment Effect
scale. Analysis of variance was used to assess the UPS’s 
construct validity and responsiveness.
RESULTS: The UPS was considered an appropriate and
reasonable assessment of urinary urgency by patients 
(n = 16) and clinicians (n = 7). Data from a total of 2,686
patients from three clinical studies were analyzed; the
baseline clinical and demographic characteristics were
similar among the three patient samples. Correlations
with patient outcomes and clinical variables were small
to moderate (0.09 to 0.46, p < 0.01) with higher corre-
lations associated with disease-speciﬁc patient outcome
measures. Responsiveness was supported by improve-
ments in the UPS score at the end of treatment that were
consistently associated with signiﬁcant (p < 0.05) reduc-
tions in micturitions associated with urgency, inconti-
nence episodes, and pad use.
CONCLUSION: The UPS is a conceptually valid scale
with evidence of construct validity and responsiveness
from three clinical studies. This work demonstrates that
perceived urinary urgency and changes in urinary urgency
can be assessed.
